RAPT Therapeutics
RAPT
#6170
Rank
A$1.34 B
Marketcap
A$48.38
Share price
5.16%
Change (1 day)
135.66%
Change (1 year)

Earnings for RAPT Therapeutics (RAPT)

Earnings in 2025 (TTM): -A$0.18 Billion

According to RAPT Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$0.21 Billion a decrease over its 2023 earnings that were of -A$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for RAPT Therapeutics from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.18 Billion-12.64%
2024 -A$0.21 Billion7.11%
2023 -A$0.19 Billion48.1%
2022 -A$0.13 Billion23.97%
2021 -A$0.11 Billion30.06%
2020 -A$79.42 Million21.96%
2019 -A$65.12 Million18.1%
2018 -A$55.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.23 Billion 31.42%๐Ÿ‡บ๐Ÿ‡ธ USA